Randall Carpenter

President and CEO
Seaside Therapeutics, Inc.
Cambridge, MA, US

Dr. Carpenter has over 25 years of experience in medicine, basic science and clinical research and pharmaceutical drug development including leading several research and development teams to submit successful INDs, NDAs and sNDAs. He has held a number of leadership positions in the pharmaceutical and biotechnology industries including President and Chief Executive Officer of Sention, Vice-President of Clinical Research & Development and Regulatory Affairs at Adolor Corporation, Director of Clinical Research at Astra USA and member of the Global Therapeutic Area Team at Astra Pain Control Sweden. Prior to joining industry, Dr. Carpenter held academic faculty appointments at the University of Washington and Wake Forest University. Dr. Carpenter has co-authored 65 journal articles, holds several patents and has served as editor-in-chief or on the editorial boards of four medical journals. He has frequently been an invited speaker at national and international meetings and symposia and has been an invited visiting professor to numerous domestic and international universities and medical schools. Dr. Carpenter completed a fellowship in pharmacokinetics at the University of California San Francisco and a sabbatical in molecular biology at the University of Washington and is Board Certified in anesthesiology and pain management. Dr. Carpenter earned his MD at The University of Michigan Medical School and completed his residency at the Virginia Mason Medical Center.

None Identified